Abstract
We report development of a controllable gene editing tool that boronated gRNA, simply generated in situ, could regulate binding of gRNA molecules with either Cas9 endonuclease or target genes, thus serving as a modulator that can control CRISPR-Cas9 gene editing. Subsequent treatment with H2O2 facilitates the restoration of gene editing ability of the boronated gRNA to the level of using untreated gRNA. This is one of the few cases using small molecule to regulate CRISPR-Cas9 gene editing, which is a complement to the light approach, displaying great application potential.
Graphical abstract
We develop a controllable gene editing tools based on the CRISPR-Cas9 gene editing system. This tool can be regulated by oxidative small molecule, i.e., H2O2. Compared with the light method, the application scope of our CRISPR-Cas9 systems have been widened with the small-molecule-triggered approaches, preventing the potential damage of cells or organism caused by UV light. In addition, the gain-of-function tools are expanding the gene code expansion for mechanistic studies of target enzymes since it provides a positive route to evaluate the activity of a given enzyme in dynamic and inversible regulation of targeting cellular processes.
Data availability
Supplementary material is available free of charge via internet.
Code availability
Not applicable.
References
Anders C, Niewoehner O, Duerst A, Jinek M. Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature. 2014;513:569–73.
Brown W, Zhou W, Deiters A. Regulating CRISPR/Cas9 Function through Conditional Guide RNA Control. Chembiochem. 2021;22(1):63–72.
Chen T-J, Gao D, Zhang R-S, Zeng G-H, Yan H, Lim E, Liang F-S. Chemically controlled epigenome editing through an inducible dCas9 system. J Am Chem Soc. 2017;139:11337–40.
Chung CY-S, Timblin GA, Saijo K, Chang CJ. Versatile histochemical approach to detection of hydrogen peroxide in cells and tissues based on puromycin staining. J Am Chem Soc. 2018;140:6109–21.
Davis KM, Pattanayak V, Thompson DB, Zuris JA, Liu DR. Small molecule-triggered Cas9 protein with improved genome-editing specificity. Nat Chem Biol. 2015;11:316–8.
Emerit J, Edeas M, Bricaire F. Neurodegenerative diseases and oxidative stress. Biomed Pharm. 2004;58:39–46.
Gao Y-C, Xiong X, Wong S, Charles EJ, Lim WA, Qi LS. Complex transcriptional modulation with orthogonal and inducible dCas9 regulators. Nat Methods. 2016;13:1043–9.
Habibian M, Mckinlay C, Blake TR, Kietrys AM, Waymouth RM, Wender PA, Kool ET. Reversible RNA acylation for control of CRISPR-Cas9 gene editing. Chem Sci. 2020;11:1011–6.
Hemphill J, Borchardt EK, Brown K, Asokan A, Deiters A. Optical Control of CRISPR/Cas9 Gene Editing. J Am Chem Soc. 2015;137(17):5642–5.
Kim J, Bertozzi CR. A bioorthogonal reaction of N-oxide and boron reagents. Angew Chem Int Ed. 2015;54:15777–81.
Liu K-W, Ramli MNB, Woo CWA, Wang Y-M, Zhao T-Y, Zhang X-J, Yim G-RD, Chong B-Y, Gowher A, Chua MZH, Jung J, Lee JHJ, Tan M-H. A chemical-inducible CRISPR-Cas9 system for rapid control of genome editing. Nat Chem Biol. 2016;12:980–7.
Matés JM, Pérez-Gómez C, De Castro IN. Antioxidant enzymes and human diseases. Clin Biochem. 1999;32:595–603.
Mok BY, Kotrys AV, Raguram A, Huang TP, Mootha VK, Liu DR. CRISPR-free base editors with enhanced activity and expanded targeting scope in mitochondrial and nuclear DNA. Nat Biotechno. 2020. https://doi.org/10.1038/s41587-022-01256-8
Nabet B, Roberts JM, Buckley DL, Paulk J, Dastjerdi S, Yang A, Leggett AL, Erb MA, Lawlor MA, Souza A, Scott TG, Vittori S, Perry JA, Qi J, Winter GE, Wong K-K, Gray NS, Bradner JE. The dTAG system for immediate and target-specific protein degradation. Nat Chem Bio. 2018;14:431–41.
Nihonggaki Y, Yamamoto S, Kawano F, Suzuki H, Sato M. CRISPR-Cas9-based photoactivatable transcription system. Chem Biol. 2015a;22:169–74.
Nihonggaki Y, Kawano F, Nakajima T, Sato M. Photoactivatable CRISPR-Cas9 for optogenetic genome editing. Nat Biotech. 2015b;33:755–62.
Oakes BL, Nadler DC, Flamholz A, Fellmann C, Staahl BT, Doudna JA, Savage DF. Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch. Nat Biotech. 2016;34:646–51.
Phng LK, Gerhardt H. Angiogenesis: A team effort coordinated by Notch. Dev Cell. 2009;16:196–208.
Polstein LR, Gersbach CA. A light-inducible CRISPR-Cas9 system for control of endogenous gene activation. Nat Chem Biol. 2015;11:198–200.
Ricci CG, Chen JS, Miao Y-L, Jinek M, Doudna JA, McCammon JA, Palermo G. Deciphering off-target effects in CRISPR-Cas9 through accelerated molecular dynamics. ACS Cent Sci. 2019;5:651–62.
Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. IJBCB. 1999;39:44–84.
Wang S-R, Wu L-Y, Huang H-Y, Xiong W, Liu J, Wei L, Yin P, Tian T, Zhou X. Conditional control of RNA-guided nucleic acid cleavage and gene editing. Nat Commun. 2020;11:91.
Weng AP, Ferrando AA, Lee W, Morris JP IV, Silverman LB, Sanchez-Irizarry C, Blacklow SC, Look AT, Aster JC. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004;306:269–71.
Zhang Y, Ling X, Su X, Zhang S, Wang J, Zhang P, Feng W, Zhu YY, Liu T, Tang X. Optical Control of a CRISPR/Cas9 System for Gene Editing by Using Photolabile crRNA. Angew Chem Int Ed Engl. 2020;59(47):20895–9.
Zetsche B, Volz SE, Zhang F. A split-Cas9 architecture for inducible genome editing and transcription modulation. Nat Biotech. 2015;33:139–42.
Zhu C, Wang R, Falck JR. Mild and rapid hydroxylation of aryl/heteroaryl boronic acids and boronate esters with N-oxides. Org Lett. 2012;14:3494–7.
Acknowledgements
We thank Prof. Jason Chin of the MRC Laboratory of Molecular Biology for providing plasmids. This work was supported by the start-up fund of Huazhong University of Science and Technology (to R.W.).
Funding
This study was supported by the startup fund of Huazhong University of Science and Technology (to R.W.)
Author information
Authors and Affiliations
Contributions
J.Z.Z., H.M.H., and J.W.Z. synthesized chemicals, all the reagents used herein; J.Z.Z., H.M.H., and H.L.Z. constructed the plasmids, RNA extraction, fluorescent labeling, transfection, and transcription assays. R.W. and L.W. designed the experiments and wrote the paper.
Corresponding author
Ethics declarations
Ethics approval
Not applicable.
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Zhao, J., Hu, H., Zhou, H. et al. Reactive oxygen signaling molecule inducible regulation of CRISPR-Cas9 gene editing. Cell Biol Toxicol 39, 2421–2429 (2023). https://doi.org/10.1007/s10565-022-09723-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10565-022-09723-3